Skip to content
Home/Companies/Biotech/PipeBio

PipeBio

Biotech·Denmark·Exited 2024·Held 3yr
Entry
2021
Hold
3yr
Exit
2024

Who owns PipeBio?

PipeBio was owned by byFounders through byFounders II (2020 vintage) from 2021 to 2024, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-18

byFounders
Investor
byFounders
byFounders II · 2020 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024

More from byFounders II

Other portfolio companies in the same fund.

Aumio
Aumio
Active
HealthTechGermany· 2022
Cello
Cello
Active
SaaSGermany· 2022
Creative Force
Active
SaaSDenmark· 2022
Ento Labs
Active
ClimateTechDenmark· 2022
IXI
Active
MedTechFinland· 2022
Salto X
Active
FintechEstonia· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track PipeBio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy PipeBio?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on PipeBio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue